Abstract
Cytolethal Distending Toxin (CDT) belongs to the AB toxin family and is produced by a plethora of Gram-negative bacteria. Eight human-affecting enteropathogens harbor CDT that causes irritable bowel syndrome (IBS), dysentery, chancroid, and periodontitis worldwide. They have a novel molecular mode of action as they interfere in the eukaryotic cell-cycle progression leading to G2/M arrest and apoptosis. CDT, the first bacterial genotoxin described, is encoded in a single operon possessing three proteins, CdtA, CdtB, and CdtC. CdtA and CdtC are needed for the binding of the CDT toxin complex to the cholesterol-rich lipid domains of the host cell while the CdtB is the active moiety. Sequence and 3D structural-based analysis of CdtB showed similarities with nucleases and phosphatases, it was hypothesized that CdtB exercises a biochemical function identical to both these enzymes. CDT is secreted through the outer membrane vesicles from the producing bacteria. It is internalized in the target cells via clathrin-dependent endocytosis and translocated to the host cell nucleus through the Golgi complex and ER. This study discusses the virulence role of CDT, causing pathogenicity by acting as a tri-perditious complex in the CDT-producing species with an emphasis on its potential role as a biomarker and an anti-tumor agent.
Graphic abstract
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akifusa S, Heywood W, Nair SP et al (2005) Mechanism of internalization of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Microbiology 151:1395–1402. https://doi.org/10.1099/mic.0.27671-0
Asakura M, Hinenoya A, Alam MS et al (2007) An inducible lambdoid prophage encoding cytolethal distending toxin (Cdt-I) and a type III effector protein in enteropathogenic Escherichia coli. Proc Natl Acad Sci USA 104:14483–14488. https://doi.org/10.1073/pnas.0706695104
Bachran C, Hasikova R, Leysath CE et al (2014) Cytolethal distending toxin B as a cell-killing component of tumor-targeted anthrax toxin fusion proteins. Cell Death Dis 5:e1003–e1003. https://doi.org/10.1038/cddis.2013.540
Bang DD, Nielsen EM, Scheutz F et al (2003) PCR detection of seven virulence and toxin genes of Campylobacter jejuni and Campylobacter coli isolates from Danish pigs and cattle and cytolethal distending toxin production of the isolates. J Appl Microbiol 94:1003–1014. https://doi.org/10.1046/j.1365-2672.2003.01926.x
Bezine E, Vignard J, Mirey G (2014) The cytolethal distending toxin effects on mammalian cells: a DNA damage perspective. Cells 3:592–615. https://doi.org/10.3390/cells3020592
Bielaszewska M, Fell M, Greune L et al (2004) Characterization of cytolethal distending toxin genes and expression in shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect Immun 72:1812–1816. https://doi.org/10.1128/IAI.72.3.1812-1816.2004
Bielaszewska M, Sinha B, Kuczius T, Karch H (2005) Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation, and death of human endothelial cells. Infect Immun 73:552–562. https://doi.org/10.1128/IAI.73.1.552-562.2005
Boesze-Battaglia K, Alexander D, Dlakić M, Shenker BJ (2016) A journey of cytolethal distending toxins through cell membranes. Front Cell Infect Microbiol 6:1–11. https://doi.org/10.3389/fcimb.2016.00081
Cao L, Volgina A, Huang C et al (2005) Characterization of point mutations in the cdtA gene of the cytolethal distending toxin of Actinobacillus actinomycetemcomitans. Mol Microbiol 58:1303–1321. https://doi.org/10.1111/j.1365-2958.2005.04905.x
Chen Y-A, Lai Y-R, Wu H-Y et al (2021) Bacterial genotoxin-coated nanoparticles for radiotherapy sensitization in prostate cancer. Biomedicines 9:151. https://doi.org/10.3390/biomedicines9020151
Chien CC, Taylor NS, Ge Z et al (2000) Identification of cdtB homologues and cytolethal distending toxin activity in enterohepatic Helicobacter spp. J Med Microbiol 49:525–534. https://doi.org/10.1099/0022-1317-49-6-525
Comayras C, Tasca C, Pérès SY et al (1997) Escherichia coli cytolethal distending toxin blocks the HeLa cell cycle at the G2/M transition by preventing cdc2 protein kinase dephosphorylation and activation. Infect Immun 65:5088–5095
Cope LD, Lumbley S, Latimer JL et al (1997) A diffusible cytotoxin of Haemophilus ducreyi. Proc Natl Acad Sci USA 94:4056–4061. https://doi.org/10.1073/pnas.94.8.4056
Cortes-Bratti X, Chaves-Olarte E, Lagergård T, Thelestam M (1999) The cytolethal distending toxin from the chancroid bacterium Haemophilus ducreyi induces cell-cycle arrest in the G2 phase. J Clin Invest 103:107–115. https://doi.org/10.1172/JCI3831
Cortes-Bratti X, Frisan T, Thelestam M (2001) The cytolethal distending toxins induce DNA damage and cell cycle arrest. Toxicon 39:1729–1736. https://doi.org/10.1016/S0041-0101(01)00159-3
Damek-Poprawa M, Haris M, Volgina A et al (2011) Cytolethal distending toxin damages the oral epithelium of gingival explants. J Dent Res 90:874–879. https://doi.org/10.1177/0022034511403743
Dang DB, Borck B, Nielsen EM et al (2004) Detection of seven virulence and toxin genes of Campylobacter jejuni isolates from Danish turkeys by PCR and cytolethal distending toxin production of the isolates. J Food Prot 67:2171–2177. https://doi.org/10.4315/0362-028x-67.10.2171
de Rycke J, Oswald E (2001) Cytolethal distending toxin (CDT): a bacterial weapon to control host cell proliferation? FEMS Microbiol Lett 203:141–148. https://doi.org/10.1111/J.1574-6968.2001.TB10832.X
DiRienzo JM (2014) Uptake and processing of the cytolethal distending toxin by mammalian cells. Toxins (Basel) 6:3098–3116. https://doi.org/10.3390/toxins6113098
DiRienzo JM (2014) Cytolethal distending toxin: a unique variation on the AB toxin paradigm. New J Sci 2014:1–26. https://doi.org/10.1155/2014/249056
DiRienzo JM, Cao L, Volgina A et al (2009) Functional and structural characterization of chimeras of a bacterial genotoxin and human type I DNAse. FEMS Microbiol Lett 291:222–231. https://doi.org/10.1111/j.1574-6968.2008.01457.x
Dlakic M (2001) Is CdtB a nuclease or a phosphatase? Science (80-) 291:547. https://doi.org/10.1126/science.291.5504.547a
Dlakić M (2000) Functionally unrelated signalling proteins contain a fold similar to Mg2+-dependent endonucleases. Trends Biochem Sci 25:272–273. https://doi.org/10.1016/S0968-0004(00)01582-6
Elwell CA, Dreyfus LA (2000) DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol 37:952–963. https://doi.org/10.1046/j.1365-2958.2000.02070.x
Fouts DE, Mongodin EF, Mandrell RE et al (2005) Major structural differences and novel potential virulence mechanisms from the genomes of multiple Campylobacter Species. PLoS Biol. https://doi.org/10.1371/journal.pbio.0030015
Fox JG (2007) Helicobacter bilis: Bacterial provocateur orchestrates host immune responses to commensal flora in a model of inflammatory bowel disease. Gut 56:898–900
Fox JG, Ackerman JI, Taylor N et al (1987) Campylobacter jejuni infection in the ferret: an animal model of human campylobacteriosis. Am J Vet Res 48:85–90
Fox JG, Dewhirst FE, Tully JG et al (1994) Helicobacter hepaticus sp. nov., a microaerophilic bacterium isolated from livers and intestinal mucosal scrapings from mice. J Clin Microbiol 32:1238–1245
Fox JG, Drolet R, Higgins R et al (1996) Helicobacter canis isolated from a dog liver with multifocal necrotizing hepatitis. J Clin Microbiol 34:2479–2482. https://doi.org/10.1128/jcm.34.10.2479-2482.1996
Frisan T (2016) Bacterial genotoxins: the long journey to the nucleus of mammalian cells. Biochim Biophys Acta - Biomembr 1858:567–575
Galán JE (2016) Typhoid toxin provides a window into typhoid fever and the biology of Salmonella typhi. Proc Natl Acad Sci USA 113:6338–6344. https://doi.org/10.1073/pnas.1606335113
Guerra L, Cortes-Bratti X, Guidi R, Frisan T (2011) The biology of the cytolethal distending toxins. Toxins (Basel) 3:172–190. https://doi.org/10.3390/toxins3030172
Guerra L, Nemec KN, Massey S et al (2009) A novel mode of translocation for cytolethal distending toxin. Biochim Biophys Acta - Mol Cell Res 1793:489–495. https://doi.org/10.1016/j.bbamcr.2008.11.017
Guerra L, Teter K, Lilley BN et al (2005) Cellular internalization of cytolethal distending toxin: a new end to a known pathway. Cell Microbiol 7:921–934. https://doi.org/10.1111/j.1462-5822.2005.00520.x
Haghjoo E, Galán JE (2004) Salmonella typhi encodes a functional cytolethal distending toxin that is delivered into host cells by a bacterial-internalization pathway. Proc Natl Acad Sci USA 101:4614–4619. https://doi.org/10.1073/pnas.0400932101
Heywood W, Henderson B, Nair SP (2005) Cytolethal distending toxin: creating a gap in the cell cycle. J Med Microbiol 54:207–216. https://doi.org/10.1099/jmm.0.45694-0
Hu X, Nesic D, Stebbins CE (2006) Comparative structure-function analysis of cytolethal distending toxins. Proteins Struct Funct Genet 62:421–434. https://doi.org/10.1002/PROT.20767
Hu X, Stebbins CE (2006) Dynamics and assembly of the cytolethal distending toxin. Proteins Struct Funct Bioinf 65:843–855. https://doi.org/10.1002/prot.21167
Jinadasa RN, Bloom SE, Weiss RS, Duhamel GE (2011) Cytolethal distending toxin: a conserved bacterial genotoxin that blocks cell cycle progression, leading to apoptosis of a broad range of mammalian cell lineages. Microbiology 157:1521–1875. https://doi.org/10.1099/mic.0.049536-0
Johnson WM, Lior H (1987) Response of Chinese hamster ovary cells to a cytolethal distending toxin (CDT) of Escherichia coli and possible misinterpretation as heat-labile (LT) enterotoxin. FEMS Microbiol Lett 43:19–23. https://doi.org/10.1111/j.1574-6968.1987.tb02091.x
Johnson WM, Lior H (1987) Production of Shiga toxin and a cytolethal distending toxin (CLDT) by serogroups of Shigella spp. FEMS Microbiol Lett 48:235–238. https://doi.org/10.1111/j.1574-6968.1987.tb02548.x
Johnson WM, Lior H (1988) A new heat-labile cytolethal distending toxin (CLDT) produced by Campylobacter spp. Microb Pathog 4:115–126. https://doi.org/10.1016/0882-4010(88)90053-8
Kim JH, Lin E, Pimentel M (2017) Biomarkers of irritable bowel syndrome. J Neurogastroenterol Motil 23:20–26
Lai C-K, Chen Y-A, Lin C-J et al (2016) Molecular mechanisms and potential clinical applications of Campylobacter jejuni cytolethal distending toxin. Front Cell Infect Microbiol 6:9. https://doi.org/10.3389/fcimb.2016.00009
Lai CK, Lu YL, Hsieh JT et al (2014) Development of chitosan/heparin nanoparticle-encapsulated cytolethal distending toxin for gastric cancer therapy. Nanomedicine 9:803–817. https://doi.org/10.2217/nnm.13.54
Lara-Tejero M, Galan JE (2000) A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science (80-) 290:354–357. https://doi.org/10.1126/science.290.5490.354
Lara-Tejero M, Galán JE (2001) CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity. Infect Immun 69:4358–4365. https://doi.org/10.1128/IAI.69.7.4358-4365.2001
Li L, Ding C, Duan J et al (2013) A new functional site W115 in CdtA is critical for Aggregatibacter actinomycetemcomitans cytolethal distending toxin. PLoS ONE 8:e65729. https://doi.org/10.1371/journal.pone.0065729
Li L, Sharipo A, Chaves-Olarte E et al (2002) The Haemophilus ducreyi cytolethal distending toxin activates sensors of DNA damage and repair complexes in proliferating and non-proliferating cells. Cell Microbiol 4:87–99. https://doi.org/10.1046/j.1462-5822.2002.00174.x
Lindmark B, Rompikuntal PK, Vaitkevicius K et al (2009) Outer membrane vesicle-mediated release of cytolethal distending toxin (CDT) from Campylobacter jejuni. BMC Microbiol 9:220. https://doi.org/10.1186/1471-2180-9-220
Matsuo Y, Yamada A, Tsukamoto K et al (1996) A distant evolutionary relationship between bacterial sphingomyelinase and mammalian DNase I. Protein Sci 5:2459–2467. https://doi.org/10.1002/PRO.5560051208
Mayer MPA, Bueno LC, Hansen EJ, Dirienzo JM (1999) Identification of a cytolethal distending toxin gene locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans. Infect Immun 67:1227–1237
McSweeney LA, Dreyfus LA (2004) Nuclear localization of the Escherichia coli cytolethal distending toxin CdtB subunit. Cell Microbiol 6:447–458. https://doi.org/10.1111/j.1462-5822.2004.00373.x
Morales W, Rezaie A, Barlow G, Pimentel M (2019) Second-generation biomarker testing for irritable bowel syndrome using plasma anti-CdtB and anti-vinculin levels. Dig Dis Sci 64:3115–3121. https://doi.org/10.1007/s10620-019-05684-6
Naylies C, Hashim S, Lippi Y, et al (2020) Cytolethal distending toxin : from mitotic DNA damage to cGAS-dependent pro-inflammatory response. pp 1–21
Nešić D, Hsu Y, Stebbins CE (2004) Assembly and function of a bacterial genotoxin. Nature 429:429–433. https://doi.org/10.1038/nature02532
Odumosu O, Nicholas D, Yano H, Langridge W (2010) AB toxins: a paradigm switch from deadly to desirable. Toxins (Basel) 2:1612–1645
Okuda J, Fukumoto M, Takeda Y, Nishibuchi M (1997) Examination of diarrheagenicity of cytolethal distending toxin: suckling mouse response to the products of the cdtABC genes of Shigella dysenteriae. Infect Immun 65:428–433. https://doi.org/10.1128/iai.65.2.428-433.1997
Okuda J, Kurazono H, Takeda Y (1995) Distribution of the cytolethal distending toxin A gene (cdtA) among species of Shigella and Vibrio, and cloning and sequencing of the cdt gene from Shigella dysenteriae. Microb Pathog 18:167–172. https://doi.org/10.1016/S0882-4010(95)90022-5
Pérès SY, Marchès O, Daigle F et al (1997) A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol Microbiol 24:1095–1107. https://doi.org/10.1046/j.1365-2958.1997.4181785.x
Pickett CL, Cottle DL, Pesci EC, Bikah G (1994) Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect Immun 62:1046–1051. https://doi.org/10.1128/iai.62.3.1046-1051.1994
Pickett CL, Pesci EC, Cottle DL et al (1996) Prevalence of cytolethal distending toxin production in Campylobacter jejuni and relatedness of Campylobacter sp. cdtB genes. Infect Immun 64:2070–2078. https://doi.org/10.1128/iai.64.6.2070-2078.1996
Pickett CL, Whitehouse CA (1999) The cytolethal distending toxin family. Trends Microbiol 7:292–297. https://doi.org/10.1016/S0966-842X(99)01537-1
Pons BJ, Vignard J, Mirey G (2019) Cytolethal distending toxin subunit B: a review of structure-function relationship. Toxins (Basel) 11:595
Rosadi F, Fiorentini C, Fabbri A (2018) Bacterial protein toxins in human cancers. Pathog Dis 74:ftv105
Scott DA, Kaper JB (1994) Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun 62:244–251
Scuron MD, Boesze-Battaglia K, Dlakic M, Shenker BJ (2016) The cytolethal distending toxin contributes to microbial virulence and disease pathogenesis by acting as a tri-perditious toxin. Front Cell Infect Microbiol. https://doi.org/10.3389/fcimb.2016.00168
Seminario M-C, Wange RL (2003) Lipid phosphatases in the regulation of T cell activation: living up to their PTEN-tial. Immunol Rev 192:80–97. https://doi.org/10.1034/J.1600-065X.2003.00013.X
Shenker BJ, Dlakić M, Walker LP et al (2007) A novel mode of action for a microbial-derived immunotoxin: the cytolethal distending toxin subunit B exhibits phosphatidylinositol 3,4,5-triphosphate phosphatase activity. J Immunol 178:5099–5108. https://doi.org/10.4049/jimmunol.178.8.5099
Shenker BJ, Walker LP, Zekavat A et al (2014) Blockade of the PI-3K signalling pathway by the Aggregatibacter actinomycetemcomitans cytolethal distending toxin induces macrophages to synthesize and secrete pro-inflammatory cytokines. Cell Microbiol 16:1391–1404. https://doi.org/10.1111/cmi.12299
Shenker BJ, Boesze-Battaglia K, Scuron MD et al (2016a) The toxicity of the Aggregatibacter actinomycetemcomitans cytolethal distending toxin correlates with its phosphatidylinositol-3,4,5-triphosphate phosphatase activity. Cell Microbiol 18:223–243. https://doi.org/10.1111/cmi.12497
Shenker BJ, Walker LP, Zekavat A, Boesze-Battaglia K (2016b) Lymphoid susceptibility to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin is dependent upon baseline levels of the signaling lipid, phosphatidylinositol-3,4,5-triphosphate. Mol Oral Microbiol 31:33–42
Shima A, Hinenoya A, Asakura M et al (2012) Molecular characterizations of cytolethal distending toxin produced by Providencia alcalifaciens strains isolated from patients with diarrhea. Infect Immun 80:1323–1332. https://doi.org/10.1128/IAI.05831-11
Sixma TK, Pronk SE, Kalk KH et al (1991) Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 351:371–377. https://doi.org/10.1038/351371a0
Smith JL, Bayles DO (2006) The contribution of cytolethal distending toxin to bacterial pathogenesis. Crit Rev Microbiol 32:227–248. https://doi.org/10.1080/10408410601023557
Song J, Gao X, Galán JE (2013) Structure and function of the Salmonella Typhi chimaeric A 2 B 5 typhoid toxin. Nature 499:350–354. https://doi.org/10.1038/nature12377
Sugai M, Kawamoto T, Pérès SY et al (1998) The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin. Infect Immun 66:5008–5019
Taieb F, Petit C, Nougayrède J-P, Oswald E (2016) The enterobacterial genotoxins: cytolethal distending toxin and colibactin. EcoSal plus. https://doi.org/10.1128/ecosalplus.esp-0008-2016
Taylor NS, Ge Z, Shen Z et al (2003) Cytolethal distending toxin: a potential virulence factor for Helicobacter cinaedi. J Infect Dis 188:1892–1897. https://doi.org/10.1086/379837
Thelestam M, Frisan T (2004) Cytolethal distending toxins. Rev Physiol Biochem Pharmacol 152:111–133. https://doi.org/10.1007/s10254-004-0030-8
Tóth I, Hérault F, Beutin L, Oswald E (2003) Production of cytolethal distending toxins by pathogenic Escherichia coli strains isolated from human and animal sources: establishment of the existence of a new cdt variant (type IV). J Clin Microbiol 41:4285–4291. https://doi.org/10.1128/JCM.41.9.4285-4291.2003
Ueno Y, Ohara M, Kawamoto T et al (2006) Biogenesis of the Actinobacillus actinomycetemcomitans cytolethal distending toxin holotoxin. Infect Immun 74:3480–3487. https://doi.org/10.1128/IAI.00739-05
Van Den Akker F, Sarfaty S, Twiddy EM et al (1996) Crystal structure of a new heat-labile enterotoxin, LT-IIb. Structure 4:665–678. https://doi.org/10.1016/s0969-2126(96)00073-1
Verster KI, Wisecaver JH, Karageorgi M et al (2019) Horizontal transfer of bacterial cytolethal distending toxin B genes to insects. Mol Biol Evol 36:2105–2110. https://doi.org/10.1093/MOLBEV/MSZ146
Wising C, Svensson LA, Ahmed HJ et al (2002) Toxicity and immunogenicity of purified Haemophilus ducreyi cytolethal distending toxin in a rabbit model. Microb Pathog 33:49–62. https://doi.org/10.1006/MPAT.2002.0516
Young KT, Davis LM, DiRita VJ (2007) Campylobacter jejuni: molecular biology and pathogenesis. Nat Rev Microbiol 5:665–679
Young VB, Chien C, Knox KA et al (2000) Cytolethal distending toxin in avian and human isolates of Helicobacter pullorum. J Infect Dis 182:620–623. https://doi.org/10.1086/315705
Young VB, Knox KA, Schauer DB (2000) Cytolethal distending toxin sequence and activity in the enterohepatic pathogen Helicobacter hepaticus. Infect Immun 68:184–191. https://doi.org/10.1128/IAI.68.1.184-191.2000
Yue M, Yang F, Yang J et al (2009) Complete genome sequence of Haemophilus parasuis SH0165. J Bacteriol 191:1359–1360. https://doi.org/10.1128/jb.01682-08
Acknowledgements
We thank Netaji Subhas University of Technology (formerly Netaji Subhas Institute of Technology) for administrative and technical support.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
“I, as the corresponding author, declare, on behalf of all authors of the paper, that no financial conflict of interest exists in relation to the work described.”
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kailoo, S., Shreya & Kumar, Y. Cytolethal distending toxin: from genotoxin to a potential biomarker and anti-tumor target. World J Microbiol Biotechnol 37, 150 (2021). https://doi.org/10.1007/s11274-021-03117-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11274-021-03117-z